EP11.03-16 Re-immunotherapy with Nivolumab plus Ipilimumab in Advanced NSCLC Patients Previously Treated with Anti-PD-(L)1 Antibody
Autor: | Imakita, T., Fujita, K., Ito, T., Saito, Z., Oi, I., Kanai, O., Tachibana, H., Mio, T. |
---|---|
Zdroj: | In Journal of Thoracic Oncology November 2023 18(11) Supplement:S627-S627 |
Databáze: | ScienceDirect |
Externí odkaz: |